Apyx Medical Corp (APYX)
Health Care · Nasdaq
Apyx Medical is a surgical aesthetics company that designs and markets innovative plasma and electrosurgical devices for cosmetic and hospital surgical markets.
What Apyx Medical Corp does
Apyx Medical is a surgical aesthetics company that designs and markets innovative plasma and electrosurgical devices for cosmetic and hospital surgical markets. The company's core products include Renuvion (helium plasma technology for tissue contraction), J-Plasma (hospital surgical platform), and AYON (an FDA-cleared body contouring system launched commercially in 2025 that integrates fat removal, tissue contraction, and electrosurgical capabilities). The company also generates revenue through OEM agreements leveraging its expertise in unique waveforms with other medical device manufacturers.
Themes: []
Fundamentals
- Price$4.38 as of 2026-07-10 close
- Market cap$184M as of 2026-07-13
- 1-year return+102.8% as of 2026-07-10 close
- Net margin-16.4% as of 2026-07-13
- Gross margin+63.1% as of 2026-07-13
- ROE-90.6% as of 2026-07-13
- Debt / equity2.74 as of 2026-07-13
- Revenue growth (YoY)+18.2% as of 2026-07-13
- Revenue CAGR (3y)+5.9% SEC XBRL
- Beta1.39 as of 2026-07-13
Key risks (from latest filing)
[]
Competitors & peers
- Candela Medical
- Synergon
- Cutera
- Lumenis
- Cynosure
- Surgical aesthetics devices
Fundamentals: Finnhub, as of 2026-07-13. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-10.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.